Clinical trial
Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
NCT00486343 · Critical Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00486343 |
|---|---|
| Title | Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS |
| Official title | A Randomized, Double-Blind, Placebo Controlled Study of Zileuton CR Tablets Versus Placebo in Adult Patients With Poorly Controlled Asthma Patients on Moderate Dose Inhaled Corticosteroids (ICS) |
| Lead sponsor | Critical Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Zileuton CR, Placebo |
| Enrollment | 400 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jun 14, 2007 |
| Last update posted | Apr 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: